Business Building

The German healthcare landscape is on the brink of transformation, with telemedicine emerging as a critical tool in bridging gaps in patient care. This is particularly true for cannabis-based treatments, where regulatory hurdles, limited data, and stigma have traditionally constrained both access and innovation. As the German government revisits its policies on cannabis and digital […]

Opportunites and regulation in the cannabis industry are going hand in hand. A recent ruling by the Administrative Court of Düsseldorf has clarified that Dronabinol solutions provided in pre-prepared sets, like those from Caelo, cannot be classified as compounded medications. Instead, the court determined these products are finished medicinal products, requiring full regulatory approval under

New markets can only raise, when regulation changes. Thats what happened this month in a court in Düsseldorf, Germany. Its all about the question: How many work steps must be added in the pharmacy so that dronabinol can still be dispensed as a magistral preparation? According to the Düsseldorf Administrative Court (VG), testing, filling, bottling

As market uncertainty looms and valuations drop to all-time lows, the current climate offers a golden opportunity for strategic acquisitions. With elections and policy shifts on the horizon in Germany, acting decisively now could position businesses to thrive in a post-election economy. Also asking in the end of the article, if the momentum in Canada

The legalization of cannabis in Germany was meant to mark a turning point, opening the doors to a regulated and thriving market. Instead, it has unveiled a labyrinth of legal ambiguities, particularly around cannabis clones and cuttings. These essential building blocks of the industry are caught in a tangle of inconsistent interpretations, unclear definitions, and

The Polish medical cannabis market has experienced substantial growth in recent years, signaling a promising landscape for pharmaceutical entrepreneurs. With increasing societal acceptance and supportive legislative frameworks, Poland stands out as an attractive destination for investment in the medical cannabis sector. Societal Acceptance and Policy Changes A significant shift in societal attitudes towards cannabis has

Since April 1, cannabis in Germany is no longer classified under the Narcotics Act. This legislative change not only provides a new legal framework but also offers numerous opportunities for pharmacies. Although the majority of pharmacy owners initially view the partial legalization critically, some recognize the potential this market offers. According to the latest Apokix

The integration of artificial intelligence (AI) into healthcare, particularly in medication therapy management (MTM) for medical cannabis patients, presents a significant business opportunity for cannabis founders. As the use of medical cannabis becomes more widespread, the need for precise, personalized medication management grows. This article explores the potential role of AI, particularly models like ChatGPT,

In an era where the cannabis industry is experiencing rapid growth, digitization emerges as the key to unlocking success. With the recent partial legalization of cannabis in numerous regions, including a burgeoning number of cannabis clubs across Germany, the demand for reliable, secure, and intelligent software solutions has never been more pronounced. Recent incidents of